ResMed Change in AP increased by 875.8% to $103.88M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 64.6%, from $63.09M to $103.88M. Over 3 years (FY 2021 to FY 2025), Change in AP shows a downward trend with a -24.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase is generally positive for cash flow, as it allows the company to retain cash longer, provided it does not damage supplier relationships.
This measures the change in the amount the company owes to its suppliers and vendors for goods and services received. An...
Standard metric; companies often aim to optimize payment terms to maximize cash availability.
change_in_accounts_payable| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.59M | -$293.30M | -$12.39M | $27.72M | $8.04M | -$17.27M | $40.24M | $330.00K | -$1.02M | -$34.37M | $35.49M | $121.98M | -$25.44M | $4.22M | $63.09M | $49.09M | $7.64M | $10.65M | $103.88M |
| QoQ Change | — | -657.7% | +95.8% | +323.7% | -71.0% | -314.8% | +333.0% | -99.2% | -408.5% | <-999% | +203.2% | +243.7% | -120.9% | +116.6% | >999% | -22.2% | -84.4% | +39.4% | +875.8% |
| YoY Change | — | — | — | — | +102.7% | -39.4% | +45.2% | — | -112.7% | -99.0% | -11.8% | >999% | <-999% | +112.3% | +77.8% | -59.8% | +130.0% | +152.3% | +64.6% |